A leader in the success game: Aurinia Pharmaceuticals Inc (AUPH) Stock
Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]
Aurinia Pharmaceuticals Inc (AUPH) Stock Is Looking Attractive
Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]
Is Aurinia Pharmaceuticals Inc (AUPH) Stock A Better Investment Than Its Rivals?
Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]
Is Aurinia Pharmaceuticals Inc (AUPH) Stock a good value investment?
Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]
Aurinia Pharmaceuticals Inc (AUPH) Stock Is Emerging from the Clouds
Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]
Investing in Aurinia Pharmaceuticals Inc (AUPH) Stock: Methodology
Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]
Oppenheimer Sets Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Stock to “a Perform”
Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]
